Vaccine effectiveness against COVID-related hospitalization was 38% in the 2 months after receipt of one dose and 34% at 2 to 4 months.
Study: COVID booster cuts severe COVID risk by a third in patients with weak immune systems
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Global, US data show high antibiotic use, rise in resistant infections during COVID
- US respiratory virus levels continue to decline as officials track shift in SARS-CoV-2 proportions
- Study reveals promising results for abatacept for severe COVID
- Long-COVID patients more likely to report psychiatric symptoms, cost barriers to therapy